Table 1. Baseline Clinical Characteristics.
Patient Characteristic | Value |
---|---|
Age, years | 49.5 ± 11.6 |
Male | 45 (44%) |
Duration of hypertension, years | 7.5 ± 6.9 |
Height, cm | 163 ± 9 |
Body weight, kg | 67 ± 14 |
BMI, kg/m2 | 25 ± 4 |
Number of anti-hypertensive agents | 2.2 ± 1.2 |
Potassium, mmol/L | 3.4 ± 0.7 |
Creatinine, mg/dL | 1.1 ± 0.6 |
PAC, ng/dL | 61 ± 40 |
PRA, ng/mL/hour | 1.0 ± 3.1 |
Log PAC | 1.7 ± 0.3 |
Log PRA | −0.8 ± 0.8 |
Log ARR | 2.3 ± 0.9 |
SBP, mmHg | 157 ± 23 |
DBP, mmHg | 92 ± 14 |
Anti-hypertensive medication | |
CCB (%) | 75 (74%) |
ACEI | 3 (3%) |
ARB | 32 (31%) |
Diuretics | 9 (9%) |
β-blockers | 41 (40%) |
α-blockers | 32 (31%) |
Direct vasodilators | 2 (2%) |
Clonidine | 3 (3%) |
Spironolactone usage more than 8 weeks before adrenalectomy | 28 (28%) |
Values are mean ± SD. SBP = systolic blood pressure; DBP = diastolic blood pressure; CCB = calcium channel blocker; BMI = body mass index; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; PAC = plasma aldosterone concentration; PRA = plasma renin activity; Log PAC = log-transformed plasma aldosterone concentration; Log PRA = log-transformed plasma renin activity; Log ARR = log-transformed aldosterone to renin ratio.